Search research articles
Contact Us
Filters
Showing results (171-180 of 176) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 176 results.
Leukemia
|
August 27, 2010
Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype
H Grant, X Jiang, J Stebbing, et al.
Cancer Chemotherapy and Pharmacology
|
August 21, 2019
Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial
F J Esteva, Y V Baranau, V Baryash, et al.
Oncogene
|
October 18, 2016
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer
A Harrod, J Fulton, V T M Nguyen, et al.
British Journal of Cancer
|
September 8, 2012
The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma
E Hatzimichael, C Lo Nigro, L Lattanzio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2012
An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)
R C Coombes, T Tat, M L Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
E Izumchenko, K Paz, D Ciznadija, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 176) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 176 results.
Leukemia
|
August 27, 2010
Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype
H Grant, X Jiang, J Stebbing, et al.
Cancer Chemotherapy and Pharmacology
|
August 21, 2019
Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial
F J Esteva, Y V Baranau, V Baryash, et al.
Oncogene
|
October 18, 2016
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer
A Harrod, J Fulton, V T M Nguyen, et al.
British Journal of Cancer
|
September 8, 2012
The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma
E Hatzimichael, C Lo Nigro, L Lattanzio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2012
An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)
R C Coombes, T Tat, M L Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
E Izumchenko, K Paz, D Ciznadija, et al.
Page
of 18